felbamate
Generic: felbamate
Labeler: amneal pharmaceuticals llcDrug Facts
Product Profile
Brand Name
felbamate
Generic Name
felbamate
Labeler
amneal pharmaceuticals llc
Dosage Form
TABLET
Routes
Active Ingredients
felbamate 400 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
65162-734
Product ID
65162-734_28bca98d-c89a-492a-a3e5-405098e33919
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA201680
Listing Expiration
2026-12-31
Marketing Start
2011-09-16
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
65162734
Hyphenated Format
65162-734
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
felbamate (source: ndc)
Generic Name
felbamate (source: ndc)
Application Number
ANDA201680 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 400 mg/1
Packaging
- 30 TABLET in 1 BOTTLE (65162-734-03)
- 90 TABLET in 1 BOTTLE (65162-734-09)
- 270 TABLET in 1 BOTTLE (65162-734-27)
- 500 TABLET in 1 BOTTLE (65162-734-50)
Packages (4)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "28bca98d-c89a-492a-a3e5-405098e33919", "openfda": {"nui": ["N0000175753", "N0000008486"], "unii": ["X72RBB02N8"], "rxcui": ["198358", "198359"], "spl_set_id": ["aa3fd2c0-98d6-45f3-81b0-a902526214c6"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (65162-734-03)", "package_ndc": "65162-734-03", "marketing_start_date": "20110916"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (65162-734-09)", "package_ndc": "65162-734-09", "marketing_start_date": "20110916"}, {"sample": false, "description": "270 TABLET in 1 BOTTLE (65162-734-27)", "package_ndc": "65162-734-27", "marketing_start_date": "20110916"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (65162-734-50)", "package_ndc": "65162-734-50", "marketing_start_date": "20110916"}], "brand_name": "Felbamate", "product_id": "65162-734_28bca98d-c89a-492a-a3e5-405098e33919", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "65162-734", "generic_name": "Felbamate", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Felbamate", "active_ingredients": [{"name": "FELBAMATE", "strength": "400 mg/1"}], "application_number": "ANDA201680", "marketing_category": "ANDA", "marketing_start_date": "20110916", "listing_expiration_date": "20261231"}